
    
      The purpose of this study is to investigate the prognostic value of biomarkers in Heart
      Failure.Patients with confirmed diagnosis of heart failure are enrolled.The primary outcome
      is all-cause mortality based on the death certificates. The secondary outcome is readmission
      for heart failure and all-cause mortality/readmission for heart failure according to the
      patients' medical records.
    
  